Standardization and validation of a point-of-care RT-qPCR test in response to the COVID-19 pandemic

The novel coronavirus (SARS-CoV-2) is the etiological agent of the ongoing COVID-19 pandemic currently affecting 215 countries and territories. With the number of cases increasing exponentially in many nations, molecular diagnostics have become a critical component for informing decisions related to health. However, the availability of molecular diagnostics has suffered a bottleneck.